Literature DB >> 14738137

Protein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia.

Montserrat Barragán1, Clara Campàs, Beatriz Bellosillo, Joan Gil.   

Abstract

The involvement of several protein kinase pathways in the regulation of apoptosis and cell survival has been analyzed in a wide range of models. This article reviews current understanding of the protein kinases involved in the control of apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Protein kinase C (PKC), phosphatidylinositol 3-kinase (P13K) and nuclear factor-kappa B (NF-kappaB) play important roles in the survival of these leukemic cells. These survival pathways affect proteins involved in the control of apoptosis by altering their expression or function. The elucidation of the signal transduction network involved in the survival of B-CLL cells could provide novel pharmacological targets for the therapy of B-CLL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14738137     DOI: 10.1080/1042819031000110964

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

Review 1.  Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Expert Opin Investig Drugs       Date:  2012-03-09       Impact factor: 6.206

2.  Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells.

Authors:  Mercè de Frias; Daniel Iglesias-Serret; Ana M Cosialls; Llorenç Coll-Mulet; Antonio F Santidrián; Diana M González-Gironès; Esmeralda de la Banda; Gabriel Pons; Joan Gil
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

3.  Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia.

Authors:  Steven M Kornblau; Matthew Womble; Yi Hua Qiu; C Ellen Jackson; Wenjing Chen; Marina Konopleva; Elihu H Estey; Michael Andreeff
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

4.  Activation of protein kinase C{eta} by type I interferons.

Authors:  Amanda J Redig; Antonella Sassano; Beata Majchrzak-Kita; Efstratios Katsoulidis; Hui Liu; Jessica K Altman; Eleanor N Fish; Amittha Wickrema; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

5.  Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.

Authors:  Nino Porakishvili; Ketki Vispute; Andrew J Steele; Nadeeka Rajakaruna; Nina Kulikova; Tamar Tsertsvadze; Amit Nathwani; Rajendra N Damle; Edward A Clark; Kanti R Rai; Nicholas Chiorazzi; Peter M Lydyard
Journal:  Mol Med       Date:  2015-01-14       Impact factor: 6.354

6.  A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.

Authors:  Hussein Ghamlouch; Hakim Ouled-Haddou; Gandhi Damaj; Bruno Royer; Brigitte Gubler; Jean-Pierre Marolleau
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

7.  Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.

Authors:  Irene Amigo-Jiménez; Elvira Bailón; Noemí Aguilera-Montilla; María José Terol; José A García-Marco; Angeles García-Pardo
Journal:  Oncotarget       Date:  2015-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.